2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$26.73-$0.19 (-0.72%)
Price as of Aug 03, 2026 10:20 AM EDT- $1.5BMarket Cap
- 80.67%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$26.73-$0.19 (-0.72%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.92 | ||
Change | -$0.71 (-2.57%) | ||
Open | $27.41 | ||
High | $27.70 | ||
Low | $25.85 | ||
Previous Close | $27.63 | ||
Volume | 335,590 | ||
30-Day Average Volume | 498,169 | ||
1-Week Change | -2.75% | ||
1-Month Change | -9.79% | ||
1-Year Change | 80.67% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.3M | ||
Total Assets | $419.7M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$39.2M | ||
EBIT | -$23.3M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $358.5M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | 66 | ||
P/B | 4 | ||
P/E | -60 | ||
PEG | -2 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue